Titan Pharmaceuticals, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
Titan Pharmaceuticals, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net of -$2.90 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-25.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet · last filed 2022-03-25
- Titan Pharmaceuticals, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2020-12-31 was $0.00.
- Titan Pharmaceuticals, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2020-09-30 was $0.00.
- Titan Pharmaceuticals, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2020-06-30 was $0.00.
- Titan Pharmaceuticals, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2020-03-31 was -$2.90M.
- Titan Pharmaceuticals, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for fiscal 2020 was -$2.90M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 derived: sum of 2 quarters · filed 2022-03-25 | $0.00 derived: sum of 3 quarters · filed 2022-03-25 | -$2.90M 10-K · filed 2022-03-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | -$2.90M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$2.90M 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | -$2.90M 10-Q · filed 2020-05-15 |